These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36872445)

  • 21. Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta-analysis.
    Oba Y; Keeney E; Ghatehorde N; Dias S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012620. PubMed ID: 30521694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial.
    Gregoriano C; Dieterle T; Breitenstein AL; Dürr S; Baum A; Maier S; Arnet I; Hersberger KE; Leuppi JD
    Respir Res; 2018 Dec; 19(1):237. PubMed ID: 30509268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
    Krishnan JA; Nibber A; Chisholm A; Price D; Bateman ED; Bjermer L; van Boven JFM; Brusselle G; Costello RW; Dandurand RJ; Diamant Z; Van Ganse E; Gouder C; van Kampen SC; Kaplan A; Kocks J; Miravitlles M; Niimi A; Pizzichini E; Rhee CK; Soriano JB; Vogelmeier C; Román-Rodriguez M; Carter V; D'Urzo AD; Roche N
    Ann Am Thorac Soc; 2019 Sep; 16(9):1143-1150. PubMed ID: 31162945
    [No Abstract]   [Full Text] [Related]  

  • 24. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD).
    Mostafavi-Pour-Manshadi SM; Naderi N; Mancino P; Li PZ; Tan W; Bourbeau J
    COPD; 2020 Aug; 17(4):355-365. PubMed ID: 32584165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the clinical efficacy and safety of bronchial thermoplasty in the treatment of patients with severe asthma and asthma-chronic obstructive pulmonary disease overlap].
    Hu SY; Long F; Long L; Huang WT; Fu P; Dong HB; Gan JF; Huang ZH
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1071-1076. PubMed ID: 33878834
    [No Abstract]   [Full Text] [Related]  

  • 31. The impact of heart failure on the classification of COPD severity.
    Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
    J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review.
    Nielsen M; Bårnes CB; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1443-54. PubMed ID: 26251584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population.
    Guerriero M; Caminati M; Viegi G; Senna G; Pomari C
    J Asthma; 2019 Jan; 56(1):27-33. PubMed ID: 29420087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
    Kitaguchi Y; Yasuo M; Hanaoka M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():991-7. PubMed ID: 27274220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilator reversibility in asthma and COPD: findings from three large population studies.
    Janson C; Malinovschi A; Amaral AFS; Accordini S; Bousquet J; Buist AS; Canonica GW; Dahlén B; Garcia-Aymerich J; Gnatiuc L; Kowalski ML; Patel J; Tan W; Torén K; Zuberbier T; Burney P; Jarvis D
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31221806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difficulties in differential diagnosis of COPD and asthma in primary care.
    Miravitlles M; Andreu I; Romero Y; Sitjar S; Altés A; Anton E
    Br J Gen Pract; 2012 Feb; 62(595):e68-75. PubMed ID: 22520766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.
    Ismaila AS; Haeussler K; Czira A; Tongbram V; Malmenäs M; Agarwal J; Nassim M; Živković-Gojović M; Shen Y; Dong X; Duarte M; Compton C; Vogelmeier CF; Halpin DMG
    Adv Ther; 2022 Nov; 39(11):4961-5010. PubMed ID: 35857184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical Characteristics of 118 Cases of Chronic Obstructive Pulmonary Disease Complicated with Primary Bronchopulmonary Carcinoma].
    Zhao S; Nie X; Zhang L; Zhang W; Xiao H
    Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):538-542. PubMed ID: 28855034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical, physiological and radiological features of asthma with incomplete reversibility of airflow obstruction compared with those of COPD.
    Boulet LP; Turcotte H; Hudon C; Carrier G; Maltais F
    Can Respir J; 1998; 5(4):270-7. PubMed ID: 9753528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.